Treatment of antipsychotic-associated hyperglycemia with pioglitazone: A case series [7]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 4, 2007, Pages 403-404

  Edlinger, Monika ^a   Ebenbichler, Christoph ^a   Rettenbacher, Maria ^a   Fleischhacker, W Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN SENSITIZING AGENT; METFORMIN; NEUROLEPTIC AGENT; OLANZAPINE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE;

ADULT; AGED; CASE REPORT; DIABETES MELLITUS; FEMALE; GLUCOSE METABOLISM; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LETTER; MALE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; FEMALE; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; THIAZOLIDINEDIONES;

EID: 34447528934     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000264993.86029.30     Document Type: Letter

References (8)

1. Buse JB, Cavazzoni P, Hornbuckle K, et al. A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States. J Clin Epidemiol. 2003;56(2):164-170.
2. Dwyer DS, Ardizzone TD, Bradley RJ. Psychoactive drugs affect glucose transport and the regulation of glucose metabolism. Int Rev Neurobiol. 2002;51:503-530.
3. Cohen D. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature. Pharmacopsychiatry. 2004;37(1):1-11.
4. Ebenbichler CF, Laimer M, Eder U, et al. Olanzapine induces insulin resistance: results from a prospective study. J Clin Psychiatry. 2003;64:1436-1439.
5. Seaburg HL, McLendon BM, Doraiswamy PM. Olanzapine-associated severe hyperglycemia, ketonuria, and acidosis: case report and review of literature. Pharmacotherapy. 2001;21: 1448-1454.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(suppl 1):5-10.
7. Melkerson K, Dahl ML. Adverse metabolic effects associated with atypical antipsychotics. Drugs. 2004;64:701-723.
8. Engl J, Laimer M, Niederwanger A, et al. Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells. Mol Psychiatry. 2005;10:1089-1096.